PMC:7405836 / 89328-89528
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T833 | 56-64 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T834 | 56-60 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T835 | 71-79 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T836 | 71-75 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T837 | 161-169 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T838 | 161-165 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T839 | 189-197 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T840 | 189-193 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T622 | 0-200 | Sentence | denotes | Hence, the superior genetic similarity existing between SARS-CoV-2 and SARS-CoV can be utilized to repurpose vaccines that have proven in vitro efficacy against SARS-CoV to be utilized for SARS-CoV-2. |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
2477 | 56-66 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
2478 | 71-79 | Species | denotes | SARS-CoV | Tax:694009 |
2479 | 161-169 | Species | denotes | SARS-CoV | Tax:694009 |
2480 | 189-199 | Species | denotes | SARS-CoV-2 | Tax:2697049 |